Growth Hormone therapy in childhood: lights, shadows and safety workshop. 
View full programme.

Sunday, December 9, starting at 8.30.  

This programme will be live streamed via ClickMeeting.
Follow the sessions from the comfort of your home or office by joining at this link.

Therapy with recombinant human Growth Hormone (rhGH) is widely available and has been the most important treatment for several growth disorders in childhood since 1985. Scientific attention has been greatly focused on growth disorders directly involving the GH-IGF1 system and other genetic syndromes causing pre and post-natal growth insufficiency. The list of growth factors and genes involved in the complex human growth pathway has been increasing, thank to scientific research.

Learning objectives

Recognize several chronic conditions impacting on growth hormone-IGF1 axis  
Manage rhGh therapy in different conditions and comorbidities
Provide patients with more complete information on long-term advantages and safety of rhGH therapy
Improve the adherence of patients receiving growth hormone therapy in the light of a more appropriate use of rhGH therapy

Target audiences

This programme is designed for Asian paediatric endocrinologistsscientists and all healthcare professionals involved in managing children with growth hormone disorders.